SCHEMBL7311425

SCHEMBL7311425

COC(=O)c1cccc(NC(=O)c2ccccc2)c1N

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ CYP2D6 P10635 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ KDM4E B2RXH2 4/20 0.58
▸ MAPK1 P28482 3/20 0.58
▸ HSD17B10 Q99714 3/20 0.58
▸ APOBEC3A P31941 1/20 0.58
▸ APOBEC3G Q9HC16 1/20 0.58
▸ HPGD P15428 4/20 0.57
▸ ALDH1A1 P00352 2/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ MAPT P10636 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ ALOX12 P18054 1/20 0.57
▸ HDAC3 O15379 2/20 0.55
▸ HDAC1 Q13547 2/20 0.55
▸ HDAC2 Q92769 2/20 0.55
▸ MAPK10 P53779 1/20 0.53
▸ RAB9A P51151 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL505634 0.92 PDCD1 (0.60) TSHRCYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL7318242 0.90 TSHR (0.58) TSHRCYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL7315643 0.87 HDAC1 (0.64) TSHRCYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL11665959 0.86 TSHR (0.77) TSHRCYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL7323880 0.85 PTGS1 (0.59) TSHRCYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL7314121 0.85 MEN1 (0.68) TSHRKDM4EMAPK1HSD17B10HPGD
SCHEMBL11684781 0.84 MEN1 (0.66) CYP1A2CYP2D6CYP2C19KDM4EMAPK1
SCHEMBL7318284 0.84 RXFP1 (0.57) TSHRCYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL9129050 0.84 TSHR (0.61) TSHRCYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL18255503 0.83 RAB9A (0.64) TSHRCYP1A2CYP2D6CYP2C19KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0841924-B1 BENZIMIDAZOLE COMPOUNDS UNIV NEWCASTLE VENTURES LTD (GB) 2002-10-02 — — EP disclosed
US-6310082-B1 PHARMACEUTICAL COMPOSITION COMPRISING EFFECTIVE POLY(ADP-RIBOSE)POLYMERASE ENZYME INHIBITING AMOUNT OF BENZIMIDAZOLE COMPOUND OR PHARMACEUTICALLY ACCEPTABLE SALT AND/OR PRO-DRUG FORM THEREOF, WITH ACCEPTABLE CARRIER NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 2001-10-30 — — US disclosed
US-6100283-A PRODRUG PHOSPHATE DERIVATIVE FOR POLY (ADP-RIBOSE) POLYMERASE ENZYME INHIBITOR FOR ADMINISTERING IN CONJUNCTION WITH ANTITUMOR DRUG OR RADIOTHERAPY NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 2000-08-08 — — US disclosed
EP-0841924-A1 BENZIMIDAZOLE COMPOUNDS NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 1998-05-20 — — EP disclosed
WO-1997004771-A1 BENZIMIDAZOLE COMPOUNDS NEWCASTLE UNIVERSITY VENTURES LIMITED (GB) 1997-02-13 — — WO disclosed
Send feedback